The Company was incorporated and registered under the laws of the State of Delaware, US, on 30 December 2009 as a Delaware corporation with the name Cynvenio Biosystems, Inc. The Company changed its name to LungLife AI Inc. on 1 May 2019.
The Company is domiciled in the State of Delaware, US, which is its main country of operation.
Registered Office
850 New Burton Road, Suite 201, Dover, Delaware 19904
Correspondence Address
144 W. Los Angeles Avenue, Box 106-273, Moorpark, CA 93021, USA.
Company Secretary
David M Anderson
LungLife AI licensure/accreditation information posted here.